| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 08/10/2005 | CN1213768C Method of treating endotoxemia |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927231 and stress-related degenerative processes associated with aging or diseases such as cancer, neurodegenerative disease or dysregulation of redox-regulated physiological processes, indicated by prooxidative shift in plasma thiol/disulfide redox state |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | CA2178603C Transdermal therapeutical system for preventing poisoning by organophosphoric neurotoxins that consists of a combination of active substances including a parasympathomimetric and a parasympatholytic agent |
| 08/04/2005 | WO2005070443A1 Timber bark extract |
| 08/04/2005 | US20050171211 vanillylalkyl-(methyl)oxyalkyl-carbonyl derivatives; tyrosinase inhibitor; antioxidant; foods, drugs, cosmetics; reduce lipid peroxide via oxidation; prevent speckles and spots; less toxicity |
| 08/04/2005 | US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone |
| 08/04/2005 | US20050171083 Modified release pharmaceutical formulation |
| 08/04/2005 | US20050171049 Compounds for the treatment of ischemia |
| 08/04/2005 | US20050170011 H2-dissolved water and a reducing agent (sulfite, thiosulfate or ascorbic acid) with nobel metal catalyst converts oxidized subject into a reduced state, by promoting the breaking reaction of molecular hydrogen used as a substrate included in hydrogen-dissolved water into a product of active hydrogen |
| 08/04/2005 | US20050169999 beta -carotene was dissolved in n-isobutyl or isobutyl acetate, hot solvent phase was dispersed in a modified water starch solution, evaporation of solvent, drying the dispersion; obtained beta -carotene used as colorant, for food, beverages, nutrition fortified food and pharmaceuticals |
| 08/03/2005 | EP1558256A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof |
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649609A Soybean saponin-containing material and process for producing the same |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1213029C S-Ht receptor agonist and its preparing method for salt |
| 08/02/2005 | US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara |
| 08/02/2005 | US6923967 comprises xanthophyll/astaxanthin esterified with fatty acid |
| 07/28/2005 | WO2005067950A1 Kava-kava extract for reducing the toxic and side effects and composition comprising the same and preparation thereof |
| 07/28/2005 | WO2005067918A1 Active oxygen eliminator originating in natural material and use of the same |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | DE10206849A1 Phenalenon-Derivate, Verfahren zur Herstellung und Verwendung derselben Phenalenone derivatives, to processes for preparing and using the same |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556013A1 Deferacirox dispersible tablets |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646149A Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family |
| 07/21/2005 | US20050159611 Process for producing shogaols and intermediates for the synthesis thereof |
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050158396 Comprises extracts selected from of Vaccinium myrtillus, Trifolium pratense, Vitis vinifera and Thea vinensis; group consisting of anthocyanosides, isoflavone glucosides and polyphenols; and a co-active component selected from the group consisting tocopherol, ascorbic acid |
| 07/21/2005 | CA2550186A1 Antiaging composition |
| 07/20/2005 | EP1553935A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1640471A Medicine composition and its preparation method and use |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 07/14/2005 | WO2005063265A1 Active oxygen scavenger containing oceanic deep-layer water as active ingredient, dilution of oceanic deep-layer water having active oxygen scavenging capability and beverage having active oxygen scavenging capability |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050152999 supercritically extracting an herb to obtain an oil extract and a residue;extracting the residue in a water/alcohol liquid mixture to obtain a post-supercritical hydroalcoholic extract; evaporating the water/alcohol liquid to form a powdered extract; mixing the powdered extract with the oil extract. |
| 07/14/2005 | US20050152856 0.5-7% by weight of D,L- alpha -lipoic acid, 0.05-0.5% by weight of coenzyme Q-10 and 0.01-3% by weight of acetyl-L-carnitine hydrochloride; treatment of visible sun injuries caused by processes involving the action of free radicals |
| 07/13/2005 | EP1552843A1 Dioxin elimination promoter |
| 07/13/2005 | EP1552838A1 Rubrofusarin glycoside-containing composition |
| 07/13/2005 | EP1551837A1 Phosphodiesterase 4 inhibitors |
| 07/13/2005 | EP1551793A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 07/13/2005 | EP1551412A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 07/13/2005 | EP1359929B1 Phytotherapeutic composition for eliminating heavy metals |
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1637020A Polyol-ifn-beta conjugates |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1636573A Vitamin-medicine composition and its use |
| 07/13/2005 | CN1636563A 噻唑衍生物 Thiazole derivatives |
| 07/13/2005 | CN1210398C Superoxide dismutase conjugated substance and preparation method thereof |
| 07/13/2005 | CN1210038C Application of N-acetylglucosamine in the preparation of medicine for treating viscera injure due to toxication from poison and medicine |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 07/12/2005 | US6916799 Antiinflammatory agents; respiratory system disorders |
| 07/07/2005 | US20050148661 calcium is in gluconate, chloride, bromogalactogluconate, gluconolactate or carbonate form, and the magnesium is in sulfate or pidolate form |
| 07/07/2005 | US20050148498 Metalloprotease inhibiting activity, in particular collagenase and gelatinase, treating humans or mammals suffering from a condition or disease related to excessive degeneration of support by a metalloprotease; treat inflammatory diseases: arthrosis, parodontosis or ulcers |
| 07/07/2005 | US20050148058 Protein stabilization |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/06/2005 | EP1550637A1 Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
| 07/06/2005 | EP1549329A1 Extract with anti-tumor and anti-poisonous activity |
| 07/06/2005 | CN1636007A Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635890A Neuroprotective 2-pyridinamine compositions and related methods |
| 07/06/2005 | CN1635864A Oligosaccharide aldonic acids and their topical use |
| 07/06/2005 | CN1634554A Reduced glutathione soft capsule and manufacturing process thereof |
| 07/06/2005 | CN1634553A Reduced glutathione soft capsule and manufacturing process thereof |
| 07/06/2005 | CN1634546A Health food prepared by spirulina, its extracts and traditional Chinese medicine and Tibet medicine |
| 07/06/2005 | CN1634454A 'Xingnaojing' freeze dried |
| 07/06/2005 | CN1634359A Composition containing extracts of pagodatree fruits, grape seeds and peel and preparation method thereof |
| 07/06/2005 | CN1634104A Sustained release mini pills of breviscapine and its preparing process |
| 07/06/2005 | CN1634075A Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 07/06/2005 | CN1634036A Andrographolide soft capsule formulation and preparation method thereof |
| 07/06/2005 | CN1634032A Andrographolide preparation and its production method |
| 07/06/2005 | CN1634014A Sodium ferulate oral disintegrating tablet and its preparation process |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | US20050142226 Blueberries, raspberries, pomegranates and/or extracts; free radical scavenging; flavor enhancement |
| 06/29/2005 | EP1548015A1 Novel crystals |